Evidence map›Paper›PMID 41181744›Full record

ArticleCureus2025

Hypocalcemia Revisited: Thinking Outside the Box!

Hayder Al-Khalafawi, Ali Akber Rajani, Darshi Sivakumaran

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hayder Al-KhalafawiGeneral Internal Medicine, Kingston and Richmond NHS Foundation Trust, London, GBR.
Ali Akber RajaniInternal Medicine, London North West University Healthcare NHS Trust, London, GBR.
Darshi SivakumaranGeneral Internal Medicine, Kingston and Richmond NHS Foundation Trust, London, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report details the presentation of a 62-year-old man with a background of hypothyroidism, hypertension, and chronic kidney disease (CKD) who experienced fatigue with acute-on-chronic hypocalcemia. Despite receiving oral calcium carbonate with vitamin D3 (cholecalciferol) supplementation in primary care, persistent hypocalcemia in the absence of significant renal impairment and a positive response to alfacalcidol (1α-hydroxycholecalciferol) prompted further investigation into genetic causes. A final diagnosis of pseudohypoparathyroidism type 1b (PHP1b) was confirmed through genetic studies. In cases of pseudohypoparathyroidism (PHP), appropriate monitoring and timely management are essential for patient safety and favorable outcomes. This case explores the systematic approach required in the assessment of chronic hypocalcemia to discern aetiology among a wider range of differentials.

Indexed as

genetic hypocalcemiahypocalcemia causespseudohypoparathyroidismpseudohypoparathyroidism type 1bresistant hypocalcemia

Identifiers

PMID41181744
PMCPMC12574963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.